Applications due February 1, 2021 at 5pm PST
About the Inclusivity Research Initiative
The Neurotrack Inclusivity Research Initiative (NIRI) was created to address the gap that exists in Alzheimer’s research today. We are looking to support academic researchers who are dedicated to studying Alzheimer’s and other dementias in populations that are underrepresented, or not represented at all, in traditional scientific research. These populations, such as women and people of color, are at greater risk for cognitive decline which underscores the need for more diversity in research.
Through NIRI, Neurotrack will provide its battery of digital cognitive assessments, free of charge, to five researchers whose projects are focused on studying underrepresented populations. We hope to make cognitive assessment more accessible and efficient for academic researchers to achieve their research objectives.
Please note that this is NOT a funding opportunity. The awardees will be provided free access to the Neurotrack battery of digital cognitive assessments for the extent of their research project.
Also, by utilizing Neurotrack's digital cognitive assessment platform, data will be collected through our HIPAA-compliant system. To maintain privacy, any data shared with Neurotrack will be de-identified.
A common problem that exists in scientific studies is the lack of diversity among the populations being studied. This typically results in an underrepresentation of females and people of color in clinical trials, particularly when it comes Alzheimer's research. This can distort the validity of clinical conclusions, as females and people of color are often disproportionately at risk for developing neurogenic disorders such as Alzheimer's disease.
For example, females represent more than two-thirds of Alzheimer’s disease patients in the US, and similar overrepresentation exists with Black and Latino populations. Clinical research for Alzheimer’s should account for those populations in order to achieve meaningful outcomes.
Through Neurotrack's Inclusivity Research Initiative, we hope to enable research efforts to diversify Alzheimer's research and make it more inclusive and representative of all populations.
Who is Neurotrack?
Neurotrack is a digital health company on a mission to transform the diagnosis and prevention of Alzheimer's disease and related dementias. Rooted in science, we develop the latest in cognitive assessment technology and have built a suite of digital cognitive assessments that are:
Read more about our science and how we developed our cognitive assessments.
Who should apply?
Priority will be given to researchers who:
The application process involves answering questions about you, your research background, and the proposed study that would utilize Neurotrack's digital cognitive assessments.
Read through all of the information on this webpage.
Complete and submit the application form by February 1, 2021.
Neurotrack will contact you if you are selected or if we have questions about your application.
Final decisions will be announced on March 1, 2021.